Stocktoria
C4 Therapeutics, Inc. CCCC
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-10-02
C4 Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 4,551,510 | $21.0M | 4.7% |
| CITADEL ADVISORS LLC | 4,284,280 | $20.0M | 4.42% |
| TWO SIGMA INVESTMENTS, LP | 3,469,707 | $16.2M | 3.58% |
| D. E. Shaw & Co., Inc. | 1,740,989 | $8.1M | 1.8% |
| RENAISSANCE TECHNOLOGIES LLC | 1,189,828 | $5.6M | 1.23% |
| MILLENNIUM MANAGEMENT LLC | 215,386 | $1.0M | 0.22% |
| Point72 Asset Management, L.P. | 173,965 | $812,417 | 0.18% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.